CIK 0001757073 · Large accelerated filer
Envista Holdings Corp
Sign in to watch- Ticker
- NVST
- Exchange
- NYSE
- Industry
- Dental Equipment & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832206728
- Phone
- 714-817-5418
- Business address
- 200 S. KRAEMER BLVD., BLDG. E, BREA, CA, 92821
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $220,000
- in 1 filing, $220K under 10b5-1 plans
Net −$220,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-25 | Acurio Veronica President, Orthodontics | Grant or award · Employee Stock Option (Right to Buy) | +18,020 | 18,020 | ||
| 2026-02-25 | Nilsson Stefan President, Nobel Biocare | Shares withheld for taxes | −182 | $29.59 | $5K | 54,759 |
| 2026-02-25 | Nilsson Stefan President, Nobel Biocare | Grant or award | +7,605 | 62,364 | ||
| 2026-02-25 | Nilsson Stefan President, Nobel Biocare | Grant or award · Performance Share Unit | +13,845 | 13,845 | ||
| 2026-02-25 | Nilsson Stefan President, Nobel Biocare | Grant or award · Employee Stock Option (Right to Buy) | +18,020 | 18,020 | ||
| 2026-02-25 | Befidi Robert President, Diagnostics | Shares withheld for taxes | −2,177 | $29.59 | $64K | 43,327 |
| 2026-02-25 | Befidi Robert President, Diagnostics | Grant or award | +7,605 | 50,932 | ||
| 2026-02-25 | Befidi Robert President, Diagnostics | Grant or award · Performance Share Unit | +13,845 | 13,845 | ||
| 2026-02-25 | Befidi Robert President, Diagnostics | Grant or award · Employee Stock Option (Right to Buy) | +18,020 | 18,020 | ||
| 2026-02-25 | Kaabi Faez C Chief Accounting Officer | Shares withheld for taxes | −4,964 | $29.59 | $147K | 45,032 |
| 2026-02-25 | Kaabi Faez C Chief Accounting Officer | Grant or award | +13,520 | 58,552 | ||
| 2026-02-25 | Reis Mischa SVP, Strategy & Bus. Dev. | Shares withheld for taxes | −2,976 | $29.59 | $88K | 29,406 |
| 2026-02-25 | Reis Mischa SVP, Strategy & Bus. Dev. | Grant or award | +5,915 | 35,321 | ||
| 2026-02-25 | Reis Mischa SVP, Strategy & Bus. Dev. | Grant or award · Performance Share Unit | +10,770 | 10,770 | ||
| 2026-02-25 | Reis Mischa SVP, Strategy & Bus. Dev. | Grant or award · Employee Stock Option (Right to Buy) | +14,020 | 14,020 | ||
| 2026-02-25 | Nance Mark E General Counsel | Shares withheld for taxes | −3,368 | $29.59 | $100K | 68,577 |
| 2026-02-25 | Nance Mark E General Counsel | Grant or award | +12,675 | 81,252 | ||
| 2026-02-25 | Nance Mark E General Counsel | Grant or award · Performance Share Unit | +23,070 | 23,070 | ||
| 2026-02-25 | Nance Mark E General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +30,040 | 30,040 | ||
| 2026-02-25 | Keel Paul A Chief Executive Officer | Shares withheld for taxes | −11,840 | $29.59 | $350K | 335,715 |
Page 2 of 9 · 175 trades